Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage

While off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.

You May Also Be Interested In

• Trump: no talks happening or scheduled with Iran
• Buss family to sell rest of Lakers stake to Kushner, Iger - ESPN
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'